Dr Kepler Austin Davis, MD | |
2050 Walton Way Ste 101, Augusta, GA 30904-4163 | |
(706) 434-1590 | |
(706) 434-1595 |
Full Name | Dr Kepler Austin Davis |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 26 Years |
Location | 2050 Walton Way Ste 101, Augusta, Georgia |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740357425 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 82636 (Georgia) | Primary |
207RI0200X | Internal Medicine - Infectious Disease | 42178-020 (Wisconsin) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospital | Augusta, GA | Hospital |
Doctors Hospital | Augusta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Neighborhood Improvement Project Inc | 7315851078 | 50 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world.
Expanding on earlier research, Johns Hopkins researchers report that people with balance disorders or dizziness traceable to an inner-ear disturbance show distinctive abnormal eye movements when the affected ear is exposed to the strong pull of an MRI's magnetic field.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Rates of childhood obesity have tripled in the past 30 years, and food marketing has been implicated as one factor contributing to this trend. Every year, companies spend more than $10 billion in the US marketing their food and beverages to children; 98% of the food products advertised to children on television are high in fat, sugar, or sodium. In a new study scheduled for publication in The Journal of Pediatrics, researchers used neuroimaging to study the effects of food logos on obese and healthy weight children.
› Verified 3 days ago
Entity Name | Neighborhood Improvement Project Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700900867 PECOS PAC ID: 7315851078 Enrollment ID: O20031117000665 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world.
Expanding on earlier research, Johns Hopkins researchers report that people with balance disorders or dizziness traceable to an inner-ear disturbance show distinctive abnormal eye movements when the affected ear is exposed to the strong pull of an MRI's magnetic field.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Rates of childhood obesity have tripled in the past 30 years, and food marketing has been implicated as one factor contributing to this trend. Every year, companies spend more than $10 billion in the US marketing their food and beverages to children; 98% of the food products advertised to children on television are high in fat, sugar, or sodium. In a new study scheduled for publication in The Journal of Pediatrics, researchers used neuroimaging to study the effects of food logos on obese and healthy weight children.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kepler Austin Davis, MD 2050 Walton Way, Augusta, GA 30904-2305 Ph: (706) 434-1590 | Dr Kepler Austin Davis, MD 2050 Walton Way Ste 101, Augusta, GA 30904-4163 Ph: (706) 434-1590 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre, specifically designed for minimally invasive surgery.
Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world.
Expanding on earlier research, Johns Hopkins researchers report that people with balance disorders or dizziness traceable to an inner-ear disturbance show distinctive abnormal eye movements when the affected ear is exposed to the strong pull of an MRI's magnetic field.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Rates of childhood obesity have tripled in the past 30 years, and food marketing has been implicated as one factor contributing to this trend. Every year, companies spend more than $10 billion in the US marketing their food and beverages to children; 98% of the food products advertised to children on television are high in fat, sugar, or sodium. In a new study scheduled for publication in The Journal of Pediatrics, researchers used neuroimaging to study the effects of food logos on obese and healthy weight children.
› Verified 3 days ago
Dr. Bryan Richard Broach, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 | |
Dr. Kayla Ashley Shahbazian, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 Fax: 706-721-1459 | |
Dr. Harvey Schwartz, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 | |
Dr. Anam Asif Herekar, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2423 | |
Dr. Robert Allen Price, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 Magnolia Way Ste 101, Augusta, GA 30909 Phone: 706-922-6600 Fax: 706-650-0239 | |
Matthew Kevin Howard, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 818 Saint Sebastian Way, Suite 311, Augusta, GA 30901 Phone: 706-724-3473 | |
Enoch Busulwa Lule, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1350 Walton Way, Augusta, GA 30901 Phone: 706-774-5542 Fax: 706-774-5789 |